Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors
© 2017 Elsevier Masson SAS Aberrant expression of lysine specific histone demethylase 1 (LSD1) has been increasingly associated with numerous cancer cells and several proof-of-concept studies are strongly suggestive of its potential as a druggable target. Tranylcypromine (TCP) is an antidepressant o...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Elsevier Masson
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/57745 |